Key result
Neutrophil to lymphocyte ratio (OR 1.23; 95% CI 0.19-3.46; p=0.07) and platelet to lymphocyte ratio were not significant predictors of cardiac complications during thoracic oncological operations.
Why the study?
The informative value of NLR and PLR in predicting cardiac complications during thoracic oncological operations needed evaluation.
Do hematological indices (NLR and PLR) predict cardiac complications in patients undergoing thoracic oncological operations?
Observational (n=71)
Do hematological indices (NLR and PLR) predict cardiac complications in patients undergoing thoracic oncological operations?
NLR and PLR are not useful predictors of perioperative cardiac complications in patients undergoing thoracic oncological surgery.
Answers are grounded in this paper and cite their sources.
Do not adopt NLR or PLR to predict cardiac complications in thoracic oncology; leaves open their role in larger prospective studies.
Objective . To evaluate the informative value of the ratio of the absolute number of neutrophils to lymphocytes (NLR) and platelets to lymphocytes (PLR) in predicting cardiac complications during thoracic oncological operations. Materials and methods . Seventy-one patients aged 64 [60–71] years who underwent routine inpatient treatment in the thoracic surgery department were examined. Results. Concomitant cardiac diseases were diagnosed in 65 (91.6 %) patients. Cardiac complications in the form of a composite outcome were detected in 9 (12.7 %) patients, including 1 cardiac death. Both hematological indices were not predictors of CVD, both in assessing the composite outcome (NLR: OR — 1.23; 95 % CI — 0.19–3.46; p=0.07, PLR: OR — 0.85; 95 % CI — 0.89–2.02; p=0.68), and in relation to one case of cardiac mortality (p >0.05). Conclusion . The use of the hematological indices NLR and PLR cannot be recommended for predicting cardiac complications during thoracic oncological operations.
No takes yet. Share an insight, caveat, or question.
Соколов et al. (2025) conducted an observational in Thoracic oncological operations (n=71). Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) was evaluated on Cardiac complications (composite outcome) (OR 1.23, 95% CI 0.19-3.46, p=0.07). Neutrophil to lymphocyte ratio (OR 1.23; 95% CI 0.19-3.46; p=0.07) and platelet to lymphocyte ratio were not significant predictors of cardiac complications during thoracic oncological operations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: